Abstract. The effects of connexin (Cx) and its derived homotypic gap junctional intercellular communication (GJIC) between tumor cells on the invasion of metastatic cancers and the underlying mechanisms remain unclear. In this study, we investigated the influence of Cx32 and the homotypic GJIC mediated by this Cx on the migration, invasion and intercellular adhesion of transfected HeLa cells. The expression of Cx32 significantly increased cell adhesion and inhibited migration and invasion. The inhibition of GJIC by oleamide, a widely used GJIC inhibitor, reduced the enhanced adhesion and partly reversed the decreased migration and invasion that had been induced by Cx32 expression. Blockage of the p38 and extracellular signal-regulated kinase 1 and 2 mitogenactivated protein kinase (ERK1/2 MAPKs) pathways using their specific inhibitors attenuated the effects of Cx32, but not those of GJIC, on cell adhesion, migration and invasion. These results indicate that the homotypic GJIC mediated by Cx32, as well as the Cx itself, inhibit cell migration and invasion, most likely through the elevation of intercellular adhesion. The suppressive effect of Cx32 on the migration and invasion of cancer cells, but not that of its derived homotypic GJIC, partly depends on the activation of the p38 and the ERK1/2 MAPKs pathways.
Introduction
The most life-threatening attribute of cancer cells is their ability to metastasize to distant organs, a process in which invasion and migration are required. It is well known that cancer cell migration is essential for invasion (1) , which is a complex process regulated by matrix-degrading proteinases, integrins and cell-adhesion molecules that mediate tumor cell adhesion (2) . As adhesion and migration are vital events in cancer progression and particularly in invasion, the regulation of cancer cell adhesion and migration represents an attractive therapeutic target against invasive cancer.
Gap junctions composed of connexins (Cxs) mediate the direct intercellular movement of cytoplasmic signaling molecules. There are approximately 21 Cx isoforms, each of which forms channels with distinct regulatory and permeability characteristics (3) . Intercellular signaling transmission mediated by Cx channels is important in human diseases, including cancer (4) .
There is conflicting evidence regarding the effects of Cxs and their derived gap junctional intercellular communication (GJIC) on the invasion of metastatic cancers. Nicolson et al revealed a correlation between the loss of GJIC and spontaneous metastatic potential in rat 13762NF mammary adenocarcinoma cell sublines (5) . In addition, Bodenstine et al recently reported the GJIC-dependent suppression of breast cancer cell metastasis (6) . However, Fujimoto et al revealed that Cx32 suppressed the invasion of Caki-1 cells (a metastatic renal cell carcinoma cell line) partly via the inhibition of the Src-Stat3-VEGF signaling pathway, whereas treatment with 18-α-glycyrrhetinic acid (a specific inhibitor against GJIC) had no impact on Src activity, indicating that GJIC was not involved in Cx32-regulated tumor cell invasion (7) . Thus, the exact action of Cxs and GJIC on the invasive capacity of tumor cells and the underlying mechanisms remain unclear.
Several reports have indicated that Cxs act as adhesion molecules and mediate malignant tumor cell adhesion without requiring gap junction formation (8, 9) . However, other studies have revealed that heterotypic GJIC between tumor cells and surrounding epithelial cells contributes to tumor cell adhesion and migration (10) , and have confirmed the adhesive role of homotypic GJIC between tumor cells in many tumor cell lines (11) . Nevertheless, it is unclear whether homotypic GJIC-dependent intercellular adhesion correlates with the regulation of tumor cell migration and invasion.
In this study, the effects of Cx32 and its derived homotypic GJIC on the invasive properties of HeLa cells [a highly invasive cervical cancer cell line (12)] were investigated. It was noted that both Cx32 and its derived homotypic GJIC suppressed cell migration and invasion, while enhancing intercellular adhesion. Inhibitors of the p38 and extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase (ERK1/2 MAPK) pathways partly diminished the effects of Cx32 on cell adhesion, migration and invasion, but not those of GJIC, indicating that various mechanisms are responsible for the actions of this Cx and its derived GJIC. These results indicate that GJIC mediated by Cx32, as well as the Cx itself, inhibit cell migration and invasion, possibly by elevating intercellular adhesion. The suppressive effect of Cx32, but not that of its derived GJIC, on the migration and invasion of cancer cells partly depends on the activation of the p38 and ERK1/2 MAPKs pathways.
Materials and methods

Materials.
Cell culture reagents were obtained from Invitrogen. G418, hygromycin and doxycycline were obtained from Calbiochem. Calcein-acetoxymethyl ester was purchased from Molecular Probes. Oleamide was from Sigma. Mouse anti-hemiglutinin (HA) clone HA-7 immunoglobin G (IgG), alkaline phosphatase-conjugated goat anti-mouse IgG and a-tubulin polyclonal antibodies were obtained from Sigma. The p38 MAPK inhibitor, SB203580, and the ERK1/2 MAPK inhibitor, PD98059, were obtained from Merck. Anti-ERK1/2 MAPK, anti-phospho-ERK1/2 MAPK (Thr202/Tyr204), anti-p38 MAPK and anti-phospho-p38 MAPK (Thr180/ Tyr182) antibodies, and horseradish peroxidase (HRP)-labeled anti-rabbit secondary antibody were purchased from Cell Signaling. All other reagents were purchased from Sigma unless stated otherwise.
Cell culture. HeLa cells that express Cx32 under the control of a bidirectional tetracycline-inducible promoter were described and characterized previously (13) . In this stably transfected cell line, the Cx32 coding sequence is followed by a sequence coding for a thrombin-cleavable COOH-terminal epitope tag consisting of an HA epitope followed by a 6 x (His-Asn) sequence. Connexin expression was induced with doxycycline (1 µg/ml) for 48 h. Cells were cultured at 37˚C and 5% carbon dioxide (CO 2 ) in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 µg/ml G418 sulfate and 200 µg/ml hygromycin B.
Assays for cell growth/sulforhodamine B (SRB) assay.
Changes in the growth of the HeLa cells were measured using a SRB colorimetric assay (14) . Briefly, cells subjected to various treatments that match the conditions of invasion assays were grown in 96-well plates (see Cell invasion and migration assay). The culture medium was aspirated and the cells were fixed by the addition of 1 ml of 10% cold trichloroacetic acid per well at 4˚C for 30 min, then washed 5 times with deionized water and left to dry at room temperature overnight. Next, 1 ml of 0.4% SRB in 1% acetic acid solution was added to each well and the plate was left to dry again at room temperature. SRB was removed and the plates were washed 5 times with 1% acetic acid. SRB bound to the cells was solubilized with 150 µl Tris-buffer (10 µM, pH 10.5) per well and the plates were left on a plate shaker for 10 min. Absorbance was quantified using the Sunrise™ plate reader 5082 (Tecan Group Ltd., Grödig, Austria) at a wavelength of 570 nm.
Cell invasion and migration assay. The effect of Cx32 expression on the invasion of transfected HeLa cells was determined using modified Boyden chambers with transwell (Corning Costar Corp., Cambridge, MA, USA) inserts with polycarbonate membrane filters with 8-µm diameter pores (15) . The filters were pre-coated with 50 µl of Matrigel (1.25 mg/ ml). HeLa cells were serum-starved for 18 h in serum-free DMEM. The serum-starved cells were trypsinized and resuspended in DMEM, 5x10 4 cells in 100 µl of serum-free DMEM were added to the upper chamber of each well, and 600 µl of DMEM with 10% fetal bovine serum were placed in the bottom chamber. After 24 h at 37˚C, the non-invaded cells on the upper membrane surface were removed with a cotton swab. The invaded cells were fixed with 4% paraformaldehyde for 30 min and stained with 0.1% crystal violet for 30 min. High-power fields (n=8) of cells were counted in each well using an inverted microscope at x200 magnification. Invasion was expressed as the relative invasive rate, which is calculated as the invasive rate of the treated group (number of invaded cells/total cell number) divided by that of the untreated group. Meanwhile, an equal number of cells of the second group (treated and untreated) were seeded into 96-well plates at a density of 5x10 5 cells in 100 µl of serum-free DMEM per well, to match the conditions of the cell-number invasion assays. The protocol of the migration assay was the same as that of invasion assay, except that no Matrigel was used.
Short-term aggregation assay. Confluent HeLa cells were incubated in Ca 2+ /Mg 2+ -free Hank's Buffered Salt Solution containing 1 mM ethylenediaminetetraacetic acid (EDTA) for 15 min. The cells were then dissociated mechanically with a Pasteur pipette to ensure maximum separation, centrifuged at 500 rpm for 5 min and resuspended in fresh serum-free DMEM. Resuspension and centrifugation were repeated twice to remove EDTA. Runs containing cell clumps of >1% of the population were discarded. A total of 4x10 5 cells were plated in 24-well plates cultured with 400 µl of serum-free DMEM in each well. The plates were then placed on a rotary shaker (89 rpm) at 37˚C in a CO 2 incubator for 30 min and fixed by 40 µl of 4% paraformaldehyde. Cellular clusters consisting of >10 cells were considered aggregates (8) . The extent of aggregation was represented by the average percentage of aggregated cells in aggregates per field.
Dye-coupling detection by 'parachute' assay and flow cytometry. The so-called 'parachute' assay for GJIC was performed as described by Koreen et al (13) . Donor and receiver cells were grown to confluence. The donor cells were doublelabeled with 5 µΜ CellTracker™ CM-DiI, a membrane dye that does not spread to gap junction-coupled cells, and with 5 µM calcein-acetoxymethyl ester, which is converted intracellularly into calcein, a gap junction-permeable dye. The donor cells were then trypsinized and seeded onto the receiver cell monolayer at a 1:150 donor/receiver ratio. The donor cells were allowed to attach to the monolayer of receiver cells and form gap junctions for 4 h at 37˚C, and were then examined with an Olympus IX71 fluorescence microscope. For each experimental condition, we determined the average number of receiver cells containing dye per donor cell and normalized it to that of the control cultures.
To detect GJIC between suspended cells in the transwell chambers, we employed a dye-loading technique using flow cytometry as described previously (16) with a few modifications. Briefly, cells were loaded with 5 µM of the green fluorescent dye calcein-acetoxymethyl ester, which is permeable through gap junctions, as mentioned above, and could be read on the flow cytometer. After incubation for 30 min, stained cells were incubated with recipient unstained cells that were not treated with dye at a fixed ratio of 1:5 in the upper chambers of the transwells. The total cell number and density were equal to that of the invasion assay. After co-culture of these stained and unstained cells for 1 h, the cells were washed with phosphate buffered saline (PBS) supplemented with 5% fetal bovine serum, then fixed in 4% cold paraformaldehyde and analyzed by flow cytometry. GJIC was represented by the calcein geometric mean fluorescence intensity (MFI) of recipient unstained populations. To confirm that calcein dye transfer was strictly dependent on GJIC and not due to the non-specific uptake of dye, pinocytosis or lysosomal transfer, stained and unstained cells were co-cultured in the presence of 50 µM of oleamide, a GJIC blocker (17) .
Western blotting. Western blotting protocols were as in previous studies (18) . Briefly, cell lysates were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis in 10% Tris-glycine gels and transferred to a nitrocellulose (NC) membrane. Cx32 expression was evaluated on total cellular lysate by mouse anti-HA clone HA-7 IgG (U.S. Zymed) diluted 1:800 in 2.5% (w/v) skimmed dry milk in Tris-buffered saline Tween-20 (TBST; 0.01 mol/l PBS, pH 7.4, and 0.05% (v/v) Tween-20) and incubated overnight at 4˚C. The blot was then incubated with alkaline phosphataseconjugated goat anti-mouse IgG as the secondary antibody at a 1:1,600 dilution for 1 h at room temperature. Equal loading of proteins was confirmed by probing with β-tubulin diluted 1:10,000 in TBST/5% milk for 1 h at room temperature, and then probed with secondary antibody under the same conditions. For Western blot analysis of p38, phospho-p38, ERK1/2 and phospho-ERK1/2, all proteins were transferred to a NC membrane and blocked with 5% bovine serum albumin (BSA) in TBST. Blots were probed with specific antibodies raised to p38, phospho-p38, ERK1/2 and phospho-ERK1/2 (diluted with 5% BSA to 1:1,000 for p38 and phospho-p38 and 1:1,000 for ERK1/2 and phospho-ERK1/2). Non-phosphorylated MAPK bands were chosen as loading controls for the activation of MAPKs. Membranes were probed with HRP-labeled anti-rabbit secondary antibody (diluted with 5% BSA to 1:2,000; all antibodies were from Cell Signaling). Antibody binding was visualized using an enhanced chemiluminescence detection kit (ECL; Amersham International PLC, UK). All Western blotting exposures were in the linear range of detection, and the intensities of the resulting bands were quantified by Quantity One software on a GS-800 densitometer (Bio-Rad).
Statistical analysis. Data were statistically analyzed using the unpaired Student's t-test at a significance level P-value of <0.05 and are presented as the means ± standard error (SE), using Sigma Plot software (Jandel Scientific).
Results
Effect of Cx32 expression on HeLa cell invasion.
To establish whether Cx32 expression regulates tumor cell promotion, we studied the effect of forced Cx32 expression on the migratory and invasive potential of cancer cells using HeLa cells transfected with Cx32 cDNA. The overexpression of Cx32 induced by doxycycline (1 µg/ml) and GJIC revealed by the parachute assay are shown in Fig. 1 . Fig. 2A illustrates the effect of doxycycline on the invasion of HeLa cells without transfection with the Cx32-containing plasmid (wild-type HeLa cells). As shown in Fig. 2A , doxycycline itself (1 µg/ml) had no unexpected effects on the invasion of wild-type HeLa cells. Fig. 2B shows that Cx32 expression induced by doxycycline diminished cell invasion and the invasive rate of HeLa cells by ~55.7% compared to that of doxycycline-untreated cells (non-expression of Cx32). As indicated in Fig. 2C , Cx32 expression significantly suppressed HeLa cell migration through membranes that were not coated with Matrigel.
To exclude the possibility that the effect of Cx32 expression on cell migration and invasion occurred through an unspecific cytotoxicity-related mechanism, the growth rate of HeLa cells was determined using an SRB colorimetric assay. As shown in Fig. 2D , there were no statistically significant differences between the cell growth rates of cells expressing Cx32 and those cells not expressing Cx32, indicating that Cx32 expression had no cytotoxic effect on the cells.
Effects of both Cx32 and its derived homotypic GJIC on adhesion, migration and invasion of HeLa cells.
To determine whether Cx32 and/or its derived homotypic GJIC are involved in the regulation of the invasive capacity of tumor cells, the adhesion, migration and invasion of HeLa cells was assayed in the presence or absence of oleamide, a widely accepted GJIC inhibitor. Oleamide was not cytotoxic and had no effect on the invasive capacity of HeLa cells at the concentrations used in the present study (data not shown). The results of the parachute assay indicate that oleamide inhibited GJIC in a concentrationdependent manner (Fig. 3A) . Oleamide (50 µM) diminished GJIC by 95% (Fig. 3A) , but it did not change Cx32 protein levels during persistent treatment for up to 24 h (Fig. 3B) . A B Figure 3 . Oleamide (olea) diminished homotypic GJIC, but had no effect on Cx32 protein levels during its persistent treatment for up to 24 h. (A) GJIC was assessed as the average number of receiver cells containing calcein from each donor cell, normalized to the Cx32 expression group without oleamide treatment. Dye spread of cells treated with a range of oleamide concentrations. Data points represent the means ± SE from five independent experiments. (B) Western blotting showed no effect of oleamide on Cx32 protein level. Bar graphs are derived from densitometric scanning of the blots. Bars represent the means ± SE from four independent experiments.
Flow cytometry was used to determine GJIC between suspended transfected HeLa cells in the upper chamber of transwell inserts (see Materials and methods). The high sensitivity of the dye transfer flow cytometric assay allows for a precise evaluation of the amount of transferred dye in recipient unstained cells through the analysis of their MFI (19) . As shown in Fig. 4 , the MFI of recipient unstained populations of HeLa cells expressing Cx32 (middle panel) was substantially increased compared to that of cells without Cx32 expression (left panel), indicating the presence of homotypic GJIC in Cx32-expressing cells during cell invasion. Treatment of the cells expressing Cx32 with 50 µM of oleamide (right panel) significantly reversed the MFI increase of recipient unstained populations, which confirms that the dye transfer was dependent on GJIC and indicates that oleamide specifically inhibited homotypic GJIC. Fig. 5 shows that oleamide (50 µM) partly reversed the effect of Cx32 expression on cell adhesion (Fig. 5A) , migration (Fig. 5B) and invasion (Fig. 5C) . The adhesive capacity of HeLa cells not expressing Cx32 was significantly lower than that of cells expressing Cx32 after oleamide (50 µM) treatment. On the contrary, the migratory and invasive capacities of HeLa cells not expressing Cx32 were significantly greater than those of cells expressing Cx32 after oleamide treatment. These results suggest that the increased intercellular adhesion and the decreased cell migration and invasion induced by Cx32 expression occur partly through a GJIC-dependent mechanism; a GJIC-independent mechanism is also indicated. Thus, both Cx32 and its derived homotypic GJIC are critically involved in the regulation of the adhesion, migration and invasion of HeLa cells.
p38 and ERK1/2 MAPKs pathways are involved in the effects of Cx32, but not in those of its derived homotypic GJIC, on the adhesion, migration and invasion of transfected HeLa cells.
To investigate the molecular mechanism by which Cx32 expression influences the adhesive, migratory and invasive phenotypes of HeLa cells, we examined whether Cx32 expression regulated the activities of the p38 and ERK1/2 MAPKs pathways, which are closely correlated with the adhesive and migratory potential of cancer cells (20) .
The effect of Cx32 expression on the activities of p38 and ERK1/2 MAPKs, which were represented by the levels of their phosphorylated forms, is illustrated in Fig. 6 . In wild-type HeLa cells, doxycycline (1 µg/ml) did not alter the levels of phosphor-p38 (p-p38) and phosphor-ERK1/2 (p-ERK1/2), indicating that it had no effects on the activities of p38 and ERK1/2 MAPKs (Fig. 6A) . As shown in Fig. 6B , Cx32 expression significantly enhanced the activities of p38 and ERK1/2 MAPKs, as evidenced by a substantial increase in the levels of p-p38 and p-ERK1/2. The inhibition of GJIC by oleamide (50 µM) did not affect the activation of the p38 and ERK1/2 MAPKs by Cx32 expression. Pre-treatment of wild-type HeLa cells with 50 µM of oleamide for 1 h had no effect on p38 and ERK1/2 MAPKs activation (Fig. 6C) . These results suggest that Cx32 expression enhances the activities of the p38 and ERK1/2 MAPKs pathways through a GJICindependent mechanism.
Furthermore, we examined whether SB203580 (25 µM) and PD98059 (25 µM), the specific inhibitors of the p38 and ERK1/2 MAPKs, respectively, could reverse the effects of Cx32 on cell adhesion, migration and invasion.
Pre-treatment of the cells with SB203580 or PD98059 for 1 h significantly reduced the activities of the p38 and ERK1/2 MAPKs (Fig. 7A) . Moreover, treatment of the HeLa cells expressing Cx32 with SB203580 or PD98059 reversed the effects of Cx32 on adhesion (Fig. 7B), migration (Fig. 7C) and  invasion (Fig. 7D) to an extent that was indistinguishable from HeLa cells not expressing Cx32.
Consistent with the report of Ramer et al (21) , treatment of HeLa cells not expressing Cx32 with SB203580 or PD98059 did not affect adhesion and migration (data not shown). Both SB203580 and PD98059 had no impact on the growth of wild-type HeLa cells as assessed by SRB (data not shown), suggesting that the effects of these inhibitors on adhesion and migration are unrelated to cell growth.
The results indicate that Cx32, but not its derived homotypic GJIC, increases the adhesion and inhibits the migration and invasion of HeLa cells, mainly through the activation of the p38 and ERK1/2 MAPKs pathways.
Discussion
This study demonstrates the anti-invasive effect of Cx32 expression in transfected HeLa cells. Our results indicate that the overexpression of Cx32 increases intercellular adhesion and suppresses the migration and invasion of HeLa cells. These effects are partly diminished by the application of oleamide, which fully suppresses GJIC, but does not alter Cx32 protein levels. As opposed to previous studies, which reveal a Cx32-induced suppressive effect on the invasion of tumor cells in a manner independent of GJIC (7), the present study provides the first evidence for the involvement of Cx32 and its derived homotypic GJIC in the supression of HeLa cell invasion. (7). On the contrary, the expression of Cx32, which is mainly retained in the cytoplasm, has been shown to promote the progression of human ductal breast cancer cells (22) and hepatocellular carcinoma cells (23) . In addition, it has been reported that forced Cx32 expression does not affect the invasive potency of glioma cells, while it significantly increases the dye coupling between these cells (8) . These results, in combination with the data presented in this study, suggest the cell type specificity for the suppressive effects of Cx32 expression on the invasive potency of cancer cells.
Prior reports have indicated that Cxs regulate the invasion of tumor cells through various mechanisms. For example, the forced expression of Cx26 in HepG2 cells reduces their invasiveness through the suppression of matrix metallopeptidase-9 activity (24), and Cx32 expression in human renal carcinoma cells has been shown to inhibit cell invasion by blocking the Src-Stat3-VEGF signaling pathway (7) . The present study shows for the first time that the suppressive effect of Cx32 on the migration and invasion of HeLa cells partly depends on the activation of p38 and ERK1/2 MAPK pathways.
Numerous studies have indicated the vital contribution of the MAPK pathway, as well as the p38 and ERK1/2 MAPK pathways, in the regulation of migration and invasion of various cancer cell lines. However, the effects of these signaling pathways on the migration and invasion differ depending on the cell type tested. For example, constitutive p38 MAPK activity has been confirmed to be crucial for the maintenance of breast cancer invasive phenotype via the stabilization of uPA and uPAR expression (25) . Other studies have also revealed the positive regulatory role of p38 or ERK1/2 MAPK pathways in the invasive phenotype of human hepatocellular carcinoma cells and oral squamous cell carcinoma cells, respectively (26, 27) . However, cisplatin and cannabinoids have been shown to exert their anti-invasive properties on human cervical carcinoma cells (HeLa and C33A) and human lung carcinoma cells (A549) via the activation of the p38 and ERK1/2 MAPK pathways, respectively (21, 12) . In our study, the activities of p38 and ERK1/2 MAPKs were also shown to be negatively correlated with the invasive potency of HeLa cells. This evidence also indicates cell type specificity for the suppressive effects of MAPK pathway activation on the invasive potency of cancer cells. Further studies are required to demonstrate the cell type specificities for the effect of Cx32 on invasion as well as on p38 and ERK1/2 MAPK pathways. The role of the p38 and ERK1/2 MAPK pathways in the regulation of cell adhesion has been demonstrated by several studies (28, 29) . Most recently, the ERK MAPK pathway was shown to play a novel role in the dynamic remodeling of focal adhesions and the actin cytoskeleton, which are crucial determinants of cell motility (30) . However, no studies have addressed the correlations between the p38 and ERK1/2 MAPK pathways and Cx-mediated changes in adhesion, migration and invasion. It was observed that the Cx32-mediated adhesive, anti-migratory and anti-invasive effects were reversed by the inactivation of the p38 and ERK1/2 MAPKs pathways. This indicates that the concomitant activation of the p38 and ERK1/2 MAPKs pathways is critical to the enhancement of adhesion and the suppression of migration and invasion induced by Cx32 expression. Nevertheless, Cx-dependent adhesion was likely modulated by other adhesion molecules (8) , especially E-cadherin. The loss of E-cadherin-mediated adhesion led to the increased motility of tumor cells (31) . Since E-cadherin expression can be induced by Cxs (32, 33) , our study cannot fully exclude the possibility that E-cadherin may be involved in the Cx32-related increase in cell adhesion.
This study indicates that Cx32 and its derived homotypic GJIC enhance cell adhesion and reduce migration and invasion. Pre-treatment of the cells expressing Cx32 with oleamide, a GJIC inhibitor, decreases adhesion and increases migration and invasion without affecting the activities of the p38 and ERK1/2 MAPKs, suggesting that the GJIC-related effects do not occur through these pathways.
Although Cxs establish adhesive interactions independent of GJIC (8, 9) , certain reports have indicated that GJIC is sufficient for tumor cell adhesion (11, 34) . El-Sabban and Pauli reported a critical interdependence of heterotypic adhesion and GJIC between endothelial cells and lung metastatic cancer cells (35) . This type of heterotypic GJIC may trigger adhesion between tumor cells and host endothelial cells, thus contributing to the detachment of malignant cells from the tumor mass. However, consistent with the report that the Cx43-mediated homotypic GJIC between glioblastoma cells supported intercellular adhesion (11), the present study 
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indicates that homotypic GJIC is critical for the intercellular adhesion of tumor cells. Most importantly, we observed that homotypic GJIC-mediated adhesion, probably because it restricts the detachment of tumor cells from each other, is related to the decreased migration and invasion of tumor cells. Since homotypic GJIC does not alter the activities of the p38 and ERK1/2 MAPKs pathways, the mechanism by which it affects adhesion, migration and invasion requires further investigation.
